Pritish Mitra | Microbiology | Best Researcher Award

Published-on by Indian Scientist Awards

Best Researcher Award

Pritish Mitra
Ramananda College affiliated to Bankura University

Pritish Mitra
Affiliation Ramananda College affiliated to Bankura University
Country India
Scopus ID 58846340900
Documents 9
Citations 12
h-index 2
Subject Area Microbiology
Event Indian Scientist Awards
ORCID 0000-0003-3258-199X

Pritish Mitra recognizes researchers whose scholarly activities contribute to the advancement of scientific knowledge through original investigation, publication, and academic engagement. Mr. Pritish Mitra, affiliated with Ramananda College under Bankura University, has established an emerging research profile within the field of Microbiology through peer-reviewed publications and documented scholarly output indexed in Scopus.[1]

Abstract

Mr. Pritish Mitra has contributed to microbiological research through academic publications, scientific collaboration, and participation in contemporary research activities. His scholarly work demonstrates an interest in microbiology and related biological sciences while contributing to the dissemination of research findings within indexed academic literature. The available publication metrics indicate continued engagement with scientific investigation and knowledge sharing.[1]

Keywords

Microbiology, Innovative Research Award, Scientific Research, Scopus Author, Academic Publications, Biological Sciences, Research Impact, Indian Scientist Awards, Scholarly Communication, Peer-reviewed Research.

Introduction

Microbiology remains a fundamental discipline within the life sciences, supporting developments in medicine, agriculture, biotechnology, and environmental sustainability. Researchers working in this field contribute to understanding microorganisms and their interactions with living systems while advancing practical scientific applications. Recognition through academic awards encourages continued research excellence and supports broader dissemination of scientific knowledge.[2]

Research Profile

According to the available Scopus author profile, Mr. Pritish Mitra has authored nine indexed documents with twelve recorded citations and an h-index of two. These bibliometric indicators provide an overview of publication activity and scholarly visibility within indexed scientific literature.[1]

  • Affiliation with Ramananda College affiliated to Bankura University.
  • Primary research domain in Microbiology.
  • Indexed publications in Scopus.
  • Participation in scholarly communication through peer-reviewed research.

Research Contributions

The research activities associated with Mr. Mitra demonstrate continuing participation in microbiological investigation and academic publication. His contributions support the ongoing development of biological sciences by presenting research findings suitable for scientific evaluation and future investigation. Publication within indexed literature contributes to the accessibility and visibility of research outcomes for the international scientific community.[1]

Publications

The available bibliographic record reflects peer-reviewed publications indexed by Scopus. These publications collectively demonstrate scholarly productivity within the researcher’s subject area and provide measurable academic output used for research evaluation.[1]

  • 9 indexed research documents.
  • Research focused on microbiology and related biological sciences.
  • Publications supported by DOI-enabled scholarly publishing where applicable.[3]

Research Impact

Research impact may be evaluated using publication output, citation performance, collaboration, and scholarly visibility. The available bibliometric indicators demonstrate measurable engagement with the scientific community and provide evidence of continuing research dissemination through indexed academic platforms.[1]

Award Suitability

Based on the documented academic profile, publication record, and participation in microbiological research, Mr. Pritish Mitra demonstrates characteristics that align with the evaluation criteria generally associated with the Innovative Research Award presented during the Indian Scientist Awards. Assessment should continue to rely upon peer-reviewed evidence, scholarly impact, originality, and institutional evaluation.[4]

Conclusion

Mr. Pritish Mitra’s documented research activities illustrate an active commitment to microbiological investigation and scholarly publication. His Scopus-indexed publications, citation record, and institutional affiliation collectively demonstrate sustained academic engagement. Continued research productivity and scientific collaboration may further strengthen the impact of his contributions within the broader life sciences community.[1]

References

  1. . Scopus author details:  Pritish Mitra, Author ID 58846340900.

    Scopus.https://www.scopus.com/authid/detail.uri?authorId=58846340900

  2. Pritish Mitra, Orcid Profile

    https://orcid.org/0000-0003-3258-199X

  3. Google Scholar profile  (n.d.). Digital Object Identifier System.

    https://scholar.google.com/citations?hl=en&user=PT0TtFIAAAAJ
  4. A molecular docking study between heavy metals and hydrophilic Hsp70 protein to explore binding pockets

    https://link.springer.com/article/10.1007/s10708-025-11430-5

Vijay Mohan | Cancer Drug Discovery | Innovative Research Award

Published-on by Indian Scientist Awards

Innovative Research Award

Vijay Mohan
Galgotias University

Vijay Mohan
Affiliation Galgotias University
Country India
Scopus ID 57472028500
Documents 2
Citations 23
h-index 2
Subject Area Cancer Drug Discovery
Event Indian Scientist Awards

Vijay Mohan is associated with Galgotias University, India, and is engaged in research related to Cancer Drug Discovery. His academic work focuses on scientific approaches that contribute to understanding therapeutic targets, drug development strategies, and translational biomedical research. Through scholarly publications and research dissemination, he has contributed to the growing body of knowledge supporting advancements in oncology and pharmaceutical sciences.[1]

Abstract

The Innovative Research Award recognizes researchers who demonstrate originality, scientific rigor, and meaningful scholarly contributions. Vijay Mohan’s research profile reflects engagement in Cancer Drug Discovery, a field that integrates biomedical science, medicinal chemistry, pharmacology, and computational approaches to identify and develop effective therapeutic interventions. His publication and citation record illustrates active participation in scientific inquiry and knowledge dissemination within the biomedical research community.[1][2]

Keywords

Cancer Drug Discovery; Oncology Research; Therapeutic Development; Pharmaceutical Sciences; Biomedical Innovation; Precision Medicine; Drug Design; Translational Research; Cancer Therapeutics; Innovative Research.

Introduction

Cancer remains one of the most significant global health challenges, creating an ongoing need for innovative therapeutic strategies and improved treatment approaches. Cancer Drug Discovery encompasses multidisciplinary efforts directed toward identifying novel compounds, therapeutic targets, and personalized treatment methodologies. Researchers working in this field contribute to advancements that support both fundamental scientific understanding and practical clinical applications.[2]

Research Profile

Vijay Mohan is affiliated with Galgotias University and has established a documented research presence within Cancer Drug Discovery. According to available scholarly indicators, his profile includes two indexed publications, twenty-three citations, and an h-index of two. These metrics reflect research visibility and participation in academic discourse within biomedical and pharmaceutical research domains.[1]

  • Research focus on cancer therapeutics and drug discovery.
  • Interest in translational and biomedical research methodologies.
  • Contribution to scientific publication and scholarly communication.
  • Participation in interdisciplinary healthcare research initiatives.

Research Contributions

Research contributions within Cancer Drug Discovery support the identification of novel therapeutic compounds and improve understanding of disease mechanisms. Scientific efforts in this area often involve target validation, medicinal chemistry, molecular biology, and pharmacological evaluation. Such contributions assist in the development of more effective and personalized treatment strategies for cancer patients.[2]

  • Investigation of therapeutic targets relevant to oncology.
  • Support for innovative approaches to drug development.
  • Contribution to evidence-based biomedical research.
  • Participation in scientific initiatives focused on healthcare advancement.

Publications

The publication record associated with Vijay Mohan reflects scholarly engagement within biomedical and pharmaceutical research. Publications serve as an important mechanism for communicating scientific findings, facilitating peer review, and supporting future investigations in cancer-related research fields.[1]

  1. Research publications related to cancer therapeutics.
  2. Scientific articles supporting drug discovery initiatives.
  3. Peer-reviewed contributions to biomedical literature.
  4. Collaborative research outputs within healthcare sciences.

Research Impact

Research impact may be evaluated through scholarly publications, citations, academic visibility, and contribution to scientific advancement. The citation record associated with Vijay Mohan indicates engagement with the research community and demonstrates that his work has contributed to ongoing scientific discussions within cancer-related biomedical research.[1]

Award Suitability

The Innovative Research Award recognizes researchers whose scholarly activities demonstrate originality, scientific relevance, and meaningful academic contribution. Based on available research indicators and documented scientific engagement, Vijay Mohan exhibits characteristics aligned with innovative research practice through his involvement in Cancer Drug Discovery and biomedical research initiatives. These attributes support consideration within research recognition and excellence programs.[1]

Conclusion

Vijay Mohan’s research profile reflects continued engagement in Cancer Drug Discovery and biomedical research. Through scholarly publication, scientific communication, and contributions to oncology-related investigations, he participates in efforts aimed at advancing therapeutic innovation and healthcare outcomes. The Innovative Research Award provides an appropriate framework for recognizing such scholarly contributions and encouraging continued research excellence.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Vijay Mohan, Author ID 57472028500. Scopus. https://www.scopus.com/authid/detail.uri?authorId=57472028500
  2. Role of Transcription Factor BEND3 and Its Potential Effect on Cancer Progression
    https://www.mdpi.com/2072-6694/15/14/3685

Jon Jyoti Sahariah | Medicinal Chemistry | Research Excellence Award

Published-on by Indian Scientist Awards

Research Excellence Award

Jon Jyoti Sahariah
Dibrugarh University, India

Jon Jyoti Sahariah
Affiliation Dibrugarh University
Country India
Scopus ID 57225212218
Documents 19
Citations 125
h-index 6
Subject Area Medicinal Chemistry
Event Indian Scientist Awards

Jon Jyoti Sahariah is an academic researcher affiliated with Dibrugarh University, India, whose scholarly activities are associated with medicinal chemistry, pharmaceutical sciences, drug delivery systems, and therapeutic development. His published research contributions demonstrate engagement with contemporary challenges in drug discovery, targeted therapeutics, and biomedical innovation. Through peer-reviewed publications, citation impact, and interdisciplinary collaborations, he has contributed to advancing scientific understanding within medicinal chemistry and related biomedical disciplines.[1]

Abstract

This article presents an academic overview of Jon Jyoti Sahariah and his scholarly contributions within medicinal chemistry and pharmaceutical research. The profile summarizes research interests, publication records, citation metrics, scientific influence, and relevance to recognition through the Research Excellence Award. The assessment is based on publicly available scholarly indicators and peer-reviewed academic outputs.[1]

Keywords

Medicinal Chemistry, Drug Discovery, Pharmaceutical Sciences, Targeted Drug Delivery, Cancer Therapeutics, Liposomal Formulations, Biomedical Research, Therapeutic Development, Scientific Publications, Research Excellence.

Introduction

Medicinal chemistry plays a critical role in the development of novel therapeutic agents and advanced healthcare solutions. Researchers working in this field contribute to the identification, optimization, and evaluation of biologically active compounds for the prevention and treatment of diseases. Jon Jyoti Sahariah’s academic activities align with these objectives through investigations focused on pharmaceutical formulations, drug delivery systems, and therapeutic innovations. His work reflects interdisciplinary collaboration across chemistry, pharmacy, and biomedical sciences.[2]

Research Profile

The scholarly profile of Jon Jyoti Sahariah demonstrates sustained participation in scientific research and publication. According to available bibliometric indicators, his research output includes nineteen indexed documents, 125 citations, and an h-index of six. These metrics indicate measurable academic visibility and engagement within the scientific community. His publications encompass medicinal chemistry, drug delivery technologies, cancer therapeutics, and pharmaceutical innovations.[1]

  • Affiliation with Dibrugarh University, India.
  • Research specialization in medicinal chemistry and pharmaceutical sciences.
  • Indexed publications in peer-reviewed journals.
  • Interdisciplinary collaboration involving drug discovery and therapeutic development.

Research Contributions

Jon Jyoti Sahariah has contributed to studies involving natural bioactive compounds, targeted cancer therapies, liposomal drug delivery systems, and pharmaceutical technologies. Several publications examine mechanisms for improving therapeutic efficacy while reducing adverse effects associated with conventional treatments. Research efforts in these domains contribute to ongoing developments in precision medicine and translational pharmaceutical science.[3]

  • Investigation of natural compounds with therapeutic potential.
  • Research on advanced liposomal drug delivery systems.
  • Contributions to targeted cancer therapy methodologies.
  • Participation in multidisciplinary biomedical research projects.

Publications

Selected scholarly works associated with Jon Jyoti Sahariah include publications addressing cancer chemotherapy, liposomal drug delivery, and medicinal chemistry innovations. Representative studies include highly cited articles focusing on natural bioactive compounds and targeted therapeutic approaches.[3]

  1. Cancer Chemotherapy via Natural Bioactive Compounds.
  2. Advancing Liposomal Doxorubicin for Targeted Cancer Therapy.
  3. Research involving pharmaceutical formulation and drug delivery technologies.
  4. Studies related to medicinal chemistry and therapeutic development.

Research Impact

Research impact can be assessed through publication output, citation frequency, collaborative scholarship, and relevance to scientific advancement. The citation record associated with Jon Jyoti Sahariah indicates that his work has been referenced by researchers in related fields, reflecting scholarly engagement and knowledge dissemination. Contributions to pharmaceutical sciences and medicinal chemistry support ongoing scientific dialogue regarding improved therapeutic interventions.[1]

Award Suitability

The Research Excellence Award recognizes researchers demonstrating meaningful scholarly contributions, scientific productivity, and academic influence. Based on available publication records, citation metrics, and participation in medicinal chemistry research, Jon Jyoti Sahariah exhibits characteristics consistent with the objectives of academic recognition programs. His work contributes to knowledge advancement in pharmaceutical and biomedical sciences while supporting innovation in therapeutic research.[1][4]

Conclusion

Jon Jyoti Sahariah has established a scholarly profile characterized by contributions to medicinal chemistry, drug delivery systems, and pharmaceutical sciences. Through peer-reviewed publications, citation impact, and collaborative scientific efforts, he has participated in research addressing significant healthcare and therapeutic challenges. His academic record supports consideration for professional recognition through the Research Excellence Award and reflects ongoing engagement with scientific advancement.[1]

References

  1. Scopus author details: Jon Jyoti Sahariah, Author ID 57225212218. Scopus. https://www.scopus.com/authid/detail.uri?authorId=57225212218
  2. Cancer chemotherapy via natural bioactive compounds. https://www.benthamdirect.com/content/journals/cddt/10.2174/1570163819666220331095744
  3. From bench to bedside: Advancing liposomal doxorubicin for targeted cancer therapy. https://www.sciencedirect.com/science/article/pii/S2666845925000601
  4. Revolutionizing patient care: 3D printing for customized medical devices and therapeutics. https://link.springer.com/article/10.1007/s44174-025-00324-2

Tahziba Hussain | Immunology and Microbiology | Research Excellence Award

Published-on by Indian Scientist Awards

Dr. Tahziba Hussain | Immunology and Microbiology | Research Excellence Award

ICMR-RMRC, Bhubaneshwar, India

Dr. Tahziba Hussain is an accomplished scientist in biomedical research with strong academic training in zoology and immunology. She has extensive experience across premier research institutions, contributing significantly to infectious diseases and non-communicable disease studies. Her research focuses on tuberculosis, diabetes, immunology, and public health. With numerous high-impact publications and active involvement in research projects, she has also mentored many students and scholars. Her work continues to advance translational medical research and improve healthcare outcomes through scientific innovation.

Citation Metrics (Scopus)

800
600
400
50
0

Citations
761

Documents
51

h-index
17

Citations

Documents

h-index

Featured Publications

 

Rekha Bansal | Medicine and Dentistry | Research Excellence Award

Published-on by Indian Scientist Awards

Prof. Dr. Rekha Bansal | Medicine and Dentistry | Research Excellence Award

Shri Lal Bahadur Shastri Government Medical College, India

Prof. Dr. Rekha Bansal is a distinguished academician and clinician in pulmonary medicine, currently serving as Professor and Head of Department. She holds advanced qualifications in respiratory diseases and specialized training in thoracic oncology and palliative care. With extensive experience across leading medical institutions, she has contributed significantly to teaching, clinical practice, and research. Her interests include tuberculosis, lung cancer, and antimicrobial studies. Recognized for her scholarly publications and academic leadership, she continues to advance respiratory healthcare and medical education.

Citation Metrics (Google Scholar)

150
100
50
10
0

Citations
134

h-index
6

i10index
5

Citations

h-index

i10-index

Featured Publications

Hardik Kumar | Pharmaceutical Sciences | Best Researcher Award

Published-on by Indian Scientist Awards

Mr. Hardik Kumar | Pharmaceutical Sciences | Best Researcher Award

CT University,  India

Hardik Kumar is a pharmaceutical sciences academic and researcher specializing in pharmacy practice and clinical research. He holds advanced training up to doctoral coursework level, with postgraduate qualifications in pharmacy practice. His experience includes teaching, clinical exposure, pharmacovigilance activities, and academic coordination. His research interests span epilepsy, cardiometabolic disorders, infectious diseases, pharmacotherapy, drug safety, and quality-of-life assessment. He has authored multiple peer-reviewed publications, books, patents, and copyrights, received national-level awards, and actively contributes as a reviewer, speaker, and member of professional scientific bodies.

Citation Metrics (Scopus)

25
20
15
10
5
0

Citations
24

Documents
9

h-index
3

Citations

Documents

h-index

Featured Publications

Anupam Kanti Bag | Pharmacology | Best Researcher Award

Published-on by Indian Scientist Awards

Dr. Anupam Kanti Bag | Pharmacology | Best Researcher Award

Dr. B.C. Roy College of Pharmacy and Allied Health Sciences |India

Dr. Anupam Kanti Bag is an accomplished pharmacology professional with strong academic and research credentials, reflected through 142 citations, an h-index of 3, and 3 i10-index publications, demonstrating consistent scholarly impact. His expertise spans microscopy, molecular biology, behavioral analysis, molecular docking, and network pharmacology, supported by extensive laboratory experience and a solid background in pharmaceutical sciences. He has significantly contributed to innovation through multiple national and international patents in drug formulation, medical device design, and pharmacokinetic enhancement, along with authoring books and contributing chapters in emerging areas of neurodegenerative disease research. His funded research work includes projects focusing on phytochemical formulations and nano-based therapeutic applications. Dr. Bag has served in various academic, administrative, and accreditation roles, including NAAC/NBA coordination, placement operations, exam cell management, and institutional leadership responsibilities across reputed pharmacy colleges. His technical skills extend to tools such as Pyrex, Pymol, Chimera, and Biovia Studio, combined with proficiency in cell culture handling, gene assays, ADR reporting, and laboratory instrumentation. Recognized with awards for academic excellence, mentoring, and scientific presentations, he continues to contribute to the advancement of pharmacology research with dedication to innovation, collaboration, and student development.

Profile: Google Scholar

Featured Publications

Bag, A. K., & Mumtaz, S. M. F. (2013). Hepatoprotective and nephroprotective activity of hydroalcoholic extract of Ipomoea staphylina leaves. Bangladesh Journal of Pharmacology, 8(3), 263–268.

Subramaniyan, V., Shaik, S., Bag, A., Manavalan, G., & Chandiran, S. (2018). Potential action of Rumex vesicarius (L.) against potassium dichromate and gentamicin-induced nephrotoxicity in experimental rats. Pakistan Journal of Pharmaceutical Sciences, 31(2), 509–516.

Mumtaz, S. M. F., Paul, S., & Bag, A. K. (2013). Effect of Sechium edule on chemical-induced kidney damage in experimental animals. Bangladesh Journal of Pharmacology, 8(1), 28–35.

Bag, A. K., & Hiremath, S. R. R. (2023). Neuropathic pain and its management. Indian Journal of Pharmacy Practice, 16(3).

Verma, P., Munirangappa, H., Bag, A. K., & Purushottam, H. (2023). Amelioration of hyperglycemia by hydroalcoholic extract of leaves of Ecbolium viride against experimental type II model in rats.

Ramprasad Srinivasan | Biomarker | Best Researcher Award

Published-on by Indian Scientist Awards

Prof. Ramprasad Srinivasan | Biomarker | Best Researcher Award

Sri Narayani Hospital and Research Centre | India

Dr. Ramprasad Srinivasan is an accomplished biomedical researcher specializing in biochemistry, molecular biology, renal complications, and biomarker discovery. With a strong academic foundation spanning biochemistry, medical laboratory technology, and an advanced doctoral qualification, he has developed extensive expertise in molecular diagnostics and translational medicine. His professional journey includes significant scientific roles across academic institutions and advanced research laboratories, where he contributed to projects involving diabetic nephropathy, atherosclerosis, retinal disorders, inflammation, and tissue-factor–mediated signaling. He has published extensively in leading SCI journals, contributing impactful work supported by 46 citations, an h-index of 5, and documented through numerous peer-reviewed papers with a growing scientific footprint marked by his i10-index of 1. His research interests include biomarker identification, biosensor development, proteomics, macrophage biology, and chronic kidney disease mechanisms. He has also led multiple funded projects as Principal Investigator, focusing on diagnostics, CKD therapeutics, and immune regulation. His contributions have been recognized through competitive fellowships, poster awards, and travel distinctions from reputed scientific bodies. He remains committed to advancing healthcare innovations by integrating laboratory sciences with clinical applications, aiming to translate molecular insights into practical diagnostic and therapeutic solutions.

Profile: Google Scholar

Featured Publications

Nilavan, E., Sundar, S., Shenbagamoorthy, M., Narayanan, H., Nandagopal, B., & Srinivasan, R. (2020). Identification of biomarkers for early diagnosis of diabetic nephropathy disease using direct flow through mass spectrometry. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 14(6), 2073–2078.

Chaudhary, R. K., Madaboosi, N., Satija, J., Nandagopal, B., Srinivasan, R., & Sai, V. V. R. (2024). Polymeric optical fiber biosensor with PAMAM dendrimer-based surface modification and PlGF detection for pre-eclampsia diagnosis. Biosensors and Bioelectronics, 257, 116312.

Gramoll, K., & Ramaprasad, S. (1995). Effects of band weaving on fiber strength in filament-wound composite structures. Composites Engineering, 5(4), 363–373.

Srinivasan, R., Dattaguru, B., & Singh, G. (2019). Exact solutions for laminated composite beams using a unified state space formulation. International Journal for Computational Methods in Engineering Science and Mechanics.

Srinivasan, R. (2014). Exact solution of shear flexible laminated curved beams using a coupled field formulation. International Journal for Computational Methods in Engineering Science and Mechanics.

Ankush Kumar | Medicinal Chemistry | Young Researcher Award

Published-on by Indian Scientist Awards

Mr. Ankush Kumar | Medicinal Chemistry | Young Researcher Award

Chitkara University Punjab | India

Ankush Kumar is a dedicated pharmaceutical researcher whose work spans medicinal chemistry, molecular modeling, and targeted drug design with a strong focus on anticancer therapeutics. He holds a solid academic foundation with qualifications in pharmaceutical chemistry and extensive research training that includes computational drug design, structure-activity exploration, and medicinal insights into heterocyclic scaffolds. His professional experience includes serving as a Junior Research Fellow and working as an Assistant Professor across multiple academic institutions, where he contributed to teaching, mentoring, and research development. His research outputs reflect a strong contribution to oncology-oriented drug discovery, with publications covering molecular targets, biomarkers, EGFR inhibition, heterocyclic synthesis, and computational repurposing studies. He has authored numerous research papers in reputed journals, contributing to a total of 561 citations, supported by an h-index of 6 and i10-index of 4, demonstrating the growing influence of his scientific contributions. His work includes book chapters and multiple peer-reviewed articles that highlight new therapeutic strategies and structural insights into various biological targets. He has received academic distinctions such as top positions in academic competitions and has served as a reviewer for international journals, further reflecting his scholarly engagement. Overall, his research trajectory reflects a commitment to advancing pharmaceutical innovation and precision-driven drug discovery.

Profile: Google Scholar

Featured Publications

Ye, F., Dewanjee, S., Li, Y., Jha, N. K., Chen, Z. S., Kumar, A., Vishakha, Jha, S. K., et al. (2023). Advancements in clinical aspects of targeted therapy and immunotherapy in breast cancer. Molecular Cancer, 22(1), 105.

Kumar, A., Sehgal, A., Singh, S., Sharma, N., Yadav, S., Rashid, S., Ali, N., et al. (2023). Understanding the mechanistic pathways and clinical aspects associated with protein and gene based biomarkers in breast cancer. International Journal of Biological Macromolecules, Article 126595.

Zheng, M., Kumar, A., Sharma, V., Sehgal, A., Wal, P., Shinde, N. V., Kawaduji, B. S., et al. (2024). Revolutionizing pediatric neuroblastoma treatment: unraveling new molecular targets for precision interventions. Frontiers in Cell and Developmental Biology, 12, Article 1353860.

Kumar, A., Kumar, B., & Bhatia, R. (2023). Design, synthesis, molecular docking, and biological evaluation of isatin-based fused heterocycles as epidermal growth factor receptor inhibitors. Assay and Drug Development Technologies, 21(5), 222–233.

Kumar, A., Narang, R. K., & Bhatia, R. (2023). Recent advancements in NS5B inhibitors (2011–2021): Structural insights, SAR studies and clinical status. Journal of Molecular Structure, 1293, Article 136272.

Amit Nayak | Disease Survillance | Best Researcher Award

Published-on by Indian Scientist Awards

Dr. Amit Nayak | Disease Survillance | Best Researcher Award

Central India Intitute of Medical Sciences | India

Dr. Amit R. Nayak is a Senior Research Consultant and Capacity Building Lead at the Central India Institute of Medical Sciences – Advanced Research Centre. He holds a B.Sc. in Biotechnology, an M.Sc. in Biochemistry, and a Ph.D. in Biochemistry with research focused on identifying biomarkers and therapeutic agents related to acute neurological disorders. Over the course of his research career, he has worked extensively in clinical and translational neuroscience, specializing in neuroinfection, neuroinflammation, molecular diagnostics, biomarker discovery, metagenomics and infectious disease surveillance. He has contributed to more than 45 peer-reviewed publications, resulting in over 580 citations, an h-index of 15, and an i10-index of 19, reflecting the broader impact of his scientific work. His roles have included leading and coordinating multiple national and international collaborative projects as Principal Investigator and Co-Investigator funded by reputed agencies. He is also actively involved in diagnostic innovation, clinical laboratory management, ethical review processes, and research capacity development. His research output supports advancements in understanding and managing infectious and neurological disorders. He continues to contribute toward translational research that bridges laboratory investigations with meaningful clinical applications.

Profile: Scopus

Featured Publications

Nayak, A. R., et al. (2025). A biomarker based peptide immunoassay for Clostridioides difficile: Insights from Central India. International Journal of Peptide Research and Therapeutics.

Nayak, A. R., et al. (2025). Application of machine learning to identify factors affecting prevalence of Brucella: A Central India study. Conference Presentation (Open Access).

Nayak, A. R., et al. (2024). In vitro toxicity assessment of bioavailable iron in coal varieties of Central India.